PMID: 11920752Mar 29, 2002Paper

New and better protocols for a short-term Caco-2 cell culture system

Journal of Pharmaceutical Sciences
Shinji YamashitaYukihiro Furuyama

Abstract

The aim of the present study was to develop new and better protocols for a short-term Caco-2 cell culture system for use in rapid screening of intestinal drug absorption. Caco-2 cells were cultured according to several protocols for short-term cell culture to obtain monolayers. The effects of serum (fetal bovine serum, FBS) in the culture medium and of the period of cell culture on the barrier function and transporter activities of the monolayers were examined. The barrier function was estimated both from the transepithelial electrical resistance (TEER) and the permeability of [(14)C]mannitol. Transporter activities were monitored by measuring the permeability of [(14)C]glycylsarcosine for oligopeptide transporter (PepT1) and of rhodamine 123 for P-glycoprotein (P-gp). Caco-2 monolayers obtained by 3-day culture in the BIOCOAT HTS Caco-2 Assay System, developed by Becton Dickinson Bioscience, showed much higher permeability to hydrophilic compounds, such as mannitol, compared with those obtained by the standard 21-day culture system, due to the leaky structure of cell junctions. The newly developed 3-day protocol, which includes 10% FBS in the culture medium during the first day of culture, markedly enhanced TEER and lowered ma...Continue Reading

References

Mar 1, 1995·British Journal of Pharmacology·D T ThwaitesN L Simmons
Jul 1, 1996·Pharmaceutical Research·A Tsuji, I Tamai
Oct 1, 1996·Digestive Diseases and Sciences·M D BassonJ A Madri
Mar 9, 2000·Journal of Pharmaceutical Sciences·E LiangM Yazdanian
Apr 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S YamashitaH Tokuda

❮ Previous
Next ❯

Citations

May 22, 2013·Applied Microbiology and Biotechnology·Xudong DengQin Meng
Aug 4, 2005·Pharmaceutical Research·Tomoko WatanabeYuichi Sugiyama
Mar 23, 2005·Bioorganic & Medicinal Chemistry Letters·Pierre RaboissonMaxwell D Cummings
Jan 7, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Silvina A BravoBirger Brodin
Apr 2, 2003·Bioorganic & Medicinal Chemistry Letters·Bruce TomczukRoger Bone
Mar 8, 2005·Drug Discovery Today·Praveen V Balimane, Saeho Chong
Dec 4, 2004·Biological & Pharmaceutical Bulletin·Georges Da ViolantePhilippe Arnaud
Dec 12, 2012·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Zhen LiuJianshe Zhang
Aug 7, 2013·Journal of Pharmacological and Toxicological Methods·E SevinM Culot
Mar 1, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ying PengAruna Railkar
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Jianling WangDejan Bojanic
Sep 11, 2007·Journal of Pharmaceutical Sciences·Yoshiyuki ShirasakaShinji Yamashita
Oct 2, 2004·Journal of Pharmaceutical Sciences·Giuseppe TrapaniGaetano Liso
Dec 20, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Stephen T BuckleyMartin Brandl
May 21, 2011·International Journal of Pharmaceutics·Makoto KataokaShinji Yamashita
Mar 23, 2010·Journal of Pharmaceutical and Biomedical Analysis·Luciana Grazziotin RossatoFernando Remião
Dec 4, 2008·Journal of Pharmacological and Toxicological Methods·Masashi UchidaYohei Miyamoto
Jun 21, 2008·Acta Biomaterialia·Claudia PianaFranz Gabor
Mar 12, 2016·Biochemical and Biophysical Research Communications·Ryosuke NegoroHiroyuki Mizuguchi
May 4, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sanna SiissaloAnn Marie Kaukonen
Mar 12, 2016·Journal of Agricultural and Food Chemistry·Michelle H Johnson, Elvira Gonzalez de Mejia
Aug 23, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Timo KorjamoJukka Mönkkönen
May 18, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Roula Konsoula, Frank A Barile
Nov 19, 2003·AAPS PharmSci·Vanessa M D'SouzaGiovanni M Pauletti
Jul 3, 2007·Drug Metabolism and Pharmacokinetics·Tomoyuki FurubayashiToshiyasu Sakane
Jun 25, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Tomoyuki KadotaYoshiko Sugita-Konishi
Jul 19, 2014·Journal of Pharmacological and Toxicological Methods·Yike CaiHuichang Bi
Apr 6, 2017·International Journal of Molecular Sciences·Jorge HidalgoRafael A Burgos
Dec 6, 2017·BMC Complementary and Alternative Medicine·Kwang-Il ParkJin-Yeul Ma
Apr 25, 2018·Molecular Nutrition & Food Research·Ulrike MüllerJulian Weghuber
Jan 24, 2009·Journal of Burn Care & Research : Official Publication of the American Burn Association·Ken MukojimaTetsuo Yukioka
Dec 1, 2006·The Journal of Pharmacology and Experimental Therapeutics·Judith NaudVincent Pichette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.